The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating Stroke
The Effectiveness of Hyperbaric Oxygen Therapy on Pneumonia Complicating
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Yinliang Qi, M.B.B.S.
- Phone Number: +8618955133681
- Email: qiyl@mail.ustc.edu.cn
Study Locations
-
-
Anhui
-
Hefei, Anhui, China, 230000
- The Second People's Hospital of Hefei
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- New stroke events within 1-3 months (confirmed by CT and MRI)
- Moderate to severe disability (Barthel Index < 70)
- The patient is conscious, breathing autonomously, not undergoing tracheotomy or tracheal intubation for ventilator-assisted respiration
- No concurrent lower respiratory infections and other lung diseases
- The condition is relatively stable
- Cognitive function is normal to moderately impaired (Mini-Physical State Exchange, MMSE score>18)
- The Gugging Swallowing Screen (GUSS) shows swallowing difficulties
- No systemic and local use of antibiotic-containing mouthwash
Exclusion Criteria:
- A mild disability (Barthel Index > 70)
- The swallowing function is normal
- Indwelling nasogastric feeding tube
- The neurological status of the patient was significantly dynamically altered (significantly improved or worsened) in the short term prior to inclusion in the trial
- The patient had been treated with hyperbaric oxygen for other indications
- Had a chest condition and cannot withstand the pressure changes caused by hyperbaric oxygen therapy
- Have an inner ear disease
- Claustrophobia
- Communication barriers and inability to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
EXPERIMENTAL: hyperbaric oxygen therapy
Patients with stroke will receive the hyperbaric oxygen therapy (HBOT) for 40 times, which were completed on 40 business days over a 2-month period and each session lasted 90 minutes at 100% oxygen concentration and 2 atmospheres.
|
Hyperbaric oxygen therapy is the patient put in airtight oxygen tank, by increasing the air pressure in the environment (1.5 to 3.0) under atmospheric pressure, to give 100% oxygen, the patient treatment time is approximately 60 minutes to 120 minutes in this way, can achieve the purpose of greatly increase the oxygen partial pressure in the organization, so as to achieve reverse brain edema, reduce lipid peroxidation, inhibiting leukocyte hyperactivity, rebuild the blood brain barrier.
|
|
NO_INTERVENTION: Control
Stroke patients were not treated with HBOT except for the same routine treatment as the experimental group.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of pneumonia
Time Frame: 2 months
|
To calculate and compare the incidence of pneumonia between interventional group and control group, to identify whether the intervention approach could reduce the incidence.
|
2 months
|
|
Metagenomics
Time Frame: 2 months
|
To analyze and compare the effect of intervention on the diversity of bacteria in saliva samples and lower respiratory sputum samples.
|
2 months
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short Form Health Survey 12 (SF-12)
Time Frame: 2 months
|
The concise health status scale (SF-12) IS used to assess the systemic health-related quality of life in stroke patients.
It covers eight different areas: general health (GH), physical functioning (PF), bodily pain (BP), role-physical (RP), mental health (MH), vitality (VT), social functioning (SF), role-emotional (RE).
The SF-12 consists of 12 items, and each of them has its own physical component summary (PCS) and mental component summary (MCS) regression coefficients.
The response to each item will be multiplied by its PCS regression coefficient and added together with the PCS constant to provide Physical Health summary scores (SF-12 PCS).
Mental Health summary scores (SF-12 MCS) will be calculated likewise.
The higher the score, the higher the quality of life.
|
2 months
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Yinliang Qi, M.B.B.S., The Second People's Hospital of Hefei
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2018jyxm0772
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.